Free Trial

American Century Companies Inc. Boosts Holdings in DocGo Inc. (NASDAQ:DCGO)

DocGo logo with Medical background

American Century Companies Inc. lifted its stake in shares of DocGo Inc. (NASDAQ:DCGO - Free Report) by 490.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 452,254 shares of the company's stock after acquiring an additional 375,637 shares during the quarter. American Century Companies Inc. owned approximately 0.44% of DocGo worth $1,918,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently made changes to their positions in the company. JPMorgan Chase & Co. increased its holdings in DocGo by 151.1% in the third quarter. JPMorgan Chase & Co. now owns 109,855 shares of the company's stock worth $365,000 after purchasing an additional 66,097 shares in the last quarter. Matrix Asset Advisors Inc. NY acquired a new stake in DocGo in the fourth quarter worth $424,000. Rhumbline Advisers increased its stake in DocGo by 4.5% in the fourth quarter. Rhumbline Advisers now owns 142,762 shares of the company's stock valued at $605,000 after purchasing an additional 6,204 shares in the last quarter. WCM Investment Management LLC increased its stake in DocGo by 64.2% in the fourth quarter. WCM Investment Management LLC now owns 4,314,071 shares of the company's stock valued at $18,637,000 after purchasing an additional 1,687,100 shares in the last quarter. Finally, Harbor Capital Advisors Inc. raised its holdings in shares of DocGo by 37.5% during the fourth quarter. Harbor Capital Advisors Inc. now owns 1,331,928 shares of the company's stock valued at $5,647,000 after purchasing an additional 363,391 shares during the period. 56.44% of the stock is owned by institutional investors and hedge funds.

DocGo Stock Down 4.4 %

Shares of DocGo stock traded down $0.11 during trading on Friday, reaching $2.39. The company's stock had a trading volume of 1,063,222 shares, compared to its average volume of 750,055. The firm's 50-day moving average is $3.53 and its two-hundred day moving average is $3.84. DocGo Inc. has a 52-week low of $2.32 and a 52-week high of $5.68. The company has a market cap of $243.74 million, a price-to-earnings ratio of 8.54, a PEG ratio of 14.16 and a beta of 1.12.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on DCGO shares. Deutsche Bank Aktiengesellschaft downgraded DocGo from a "buy" rating to a "hold" rating and dropped their price target for the stock from $5.00 to $2.85 in a research note on Friday, February 28th. Needham & Company LLC reaffirmed a "buy" rating and set a $4.00 price target on shares of DocGo in a research report on Tuesday, April 8th. Finally, Stifel Nicolaus reduced their price objective on DocGo from $6.50 to $5.50 and set a "buy" rating for the company in a report on Friday, February 28th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $4.89.

View Our Latest Stock Report on DCGO

About DocGo

(Free Report)

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Featured Articles

Institutional Ownership by Quarter for DocGo (NASDAQ:DCGO)

Should You Invest $1,000 in DocGo Right Now?

Before you consider DocGo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.

While DocGo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines